Login to Your Account



Australia's Patrys banking nuclei-penetrating DDR antibody as game-changer

By Tamra Sami
Staff Writer

Wednesday, February 7, 2018

PERTH, Australia – Australian biotech company Patrys Ltd. is developing an antibody that can enter the cell nucleus. If clinical trials go well, it would be a game-changer, because it would mean that intracellular targets could be accessible to antibodies.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription